Maynard Um
-
-
-
-
-
-
-
Tvardi Therapeutics (TVRD) files $200M mixed shelf
-
-
-
-
-
-
-
Raymond James Downgrades Tvardi Therapeutics Inc (TVRD) to Market Perform
-
-
-
-
-
-
-
Raymond James Starts Tvardi Therapeutics Inc (TVRD) at Outperform
-
-
-
-
-
-
-
Lucid Capital Markets Starts Tvardi Therapeutics Inc (TVRD) at Buy
437,950 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

